Seroprevalence of Trypanosoma evansi in camels using CATT/T. evansi technique in Borno and Yobe states, Nigeria
Trypanosoma evansi is an important camel pathogen with dissimilar mammalian hosts and is the most widely distributed pathogenic animals' trypanosomes worldwide that affects domesticated animals. Four hundred and six blood samples were collected using homogeneous purposive sampling techniques fr...
Ausführliche Beschreibung
Autor*in: |
Falmata Kyari, PhD [verfasserIn] Albert Wulari Mbaya, PhD [verfasserIn] Abdullahi Abubakar Biu, PhD [verfasserIn] Lawan Adamu, PhD [verfasserIn] Okoro Ogbonna Dennis, MVSc [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2021 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: Parasite Epidemiology and Control - Elsevier, 2018, 13(2021), Seite e00209- |
---|---|
Übergeordnetes Werk: |
volume:13 ; year:2021 ; pages:e00209- |
Links: |
---|
DOI / URN: |
10.1016/j.parepi.2021.e00209 |
---|
Katalog-ID: |
DOAJ057023816 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ057023816 | ||
003 | DE-627 | ||
005 | 20230502133644.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230227s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.parepi.2021.e00209 |2 doi | |
035 | |a (DE-627)DOAJ057023816 | ||
035 | |a (DE-599)DOAJd58e8072a39c4a5cb9c283e77f4417ed | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RC109-216 | |
100 | 0 | |a Falmata Kyari, PhD |e verfasserin |4 aut | |
245 | 1 | 0 | |a Seroprevalence of Trypanosoma evansi in camels using CATT/T. evansi technique in Borno and Yobe states, Nigeria |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Trypanosoma evansi is an important camel pathogen with dissimilar mammalian hosts and is the most widely distributed pathogenic animals' trypanosomes worldwide that affects domesticated animals. Four hundred and six blood samples were collected using homogeneous purposive sampling techniques from camels of all age groups (206 from Borno State and 200 from Yobe State, Nigeria). Each animal was examined and information on age and gender were recorded. The card agglutination test for T. evansi (CATT/T. evansi) was used to estimate the seroprevalence of T. evansi infection. The seroprevalence of T. evansi based on age and sex in Borno State, Nigeria was 38.83% (95% CI = 32.44%, 45.63%) in adult camels, whereas, the seroprevalence of T. evansi in young camels was significantly lower 2.91%, (95% CI = 1.34%, 6.20%), p < 0.05). The seroprevalence of T. evansi in male camels was estimated at 14.08% (95% CI = 9.99, 19.49) whereas, in female camels the seroprevalence was estimated at 27.67% (95% CI = 22.01%, 34.15%, p < 0.05). Furthermore, the seroprevalence of T. evansi in Yobe State, Nigeria in the adult camels was 27.50% (95% CI = 21.78%, 34.07%) whereas, the seroprevalence of T. evansi in young camels was 19.00%, (95% CI = 14.17%, 25.00%). The seroprevalence of T. evansi in male camels was 30.0% (95% CI = 24.07%, 36.68%), whereas, the seroprevalence of T. evansi in female camels was 16.5% (95% CI = 12.00%, 22.27%). Therefore, the present study aimed to provide information on the seroprevalence of T. evansi and the related risk factors in camels in Borno and Yobe States, Nigeria using CATT/T. evansi technique. | ||
650 | 4 | |a Seroprevalence | |
650 | 4 | |a T. evansi | |
650 | 4 | |a Camels | |
650 | 4 | |a Borno | |
650 | 4 | |a Yobe | |
650 | 4 | |a Nigeria | |
653 | 0 | |a Infectious and parasitic diseases | |
700 | 0 | |a Albert Wulari Mbaya, PhD |e verfasserin |4 aut | |
700 | 0 | |a Abdullahi Abubakar Biu, PhD |e verfasserin |4 aut | |
700 | 0 | |a Lawan Adamu, PhD |e verfasserin |4 aut | |
700 | 0 | |a Okoro Ogbonna Dennis, MVSc |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Parasite Epidemiology and Control |d Elsevier, 2018 |g 13(2021), Seite e00209- |w (DE-627)861102487 |w (DE-600)2858649-9 |x 24056731 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2021 |g pages:e00209- |
856 | 4 | 0 | |u https://doi.org/10.1016/j.parepi.2021.e00209 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/d58e8072a39c4a5cb9c283e77f4417ed |z kostenfrei |
856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S2405673121000106 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2405-6731 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_224 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2001 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a GBV_ILN_2006 | ||
912 | |a GBV_ILN_2007 | ||
912 | |a GBV_ILN_2008 | ||
912 | |a GBV_ILN_2009 | ||
912 | |a GBV_ILN_2010 | ||
912 | |a GBV_ILN_2011 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_2015 | ||
912 | |a GBV_ILN_2020 | ||
912 | |a GBV_ILN_2021 | ||
912 | |a GBV_ILN_2025 | ||
912 | |a GBV_ILN_2026 | ||
912 | |a GBV_ILN_2027 | ||
912 | |a GBV_ILN_2034 | ||
912 | |a GBV_ILN_2038 | ||
912 | |a GBV_ILN_2044 | ||
912 | |a GBV_ILN_2048 | ||
912 | |a GBV_ILN_2050 | ||
912 | |a GBV_ILN_2055 | ||
912 | |a GBV_ILN_2056 | ||
912 | |a GBV_ILN_2059 | ||
912 | |a GBV_ILN_2061 | ||
912 | |a GBV_ILN_2064 | ||
912 | |a GBV_ILN_2088 | ||
912 | |a GBV_ILN_2106 | ||
912 | |a GBV_ILN_2110 | ||
912 | |a GBV_ILN_2112 | ||
912 | |a GBV_ILN_2122 | ||
912 | |a GBV_ILN_2129 | ||
912 | |a GBV_ILN_2143 | ||
912 | |a GBV_ILN_2152 | ||
912 | |a GBV_ILN_2153 | ||
912 | |a GBV_ILN_2190 | ||
912 | |a GBV_ILN_2232 | ||
912 | |a GBV_ILN_2336 | ||
912 | |a GBV_ILN_2470 | ||
912 | |a GBV_ILN_2507 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4035 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4242 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4251 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4326 | ||
912 | |a GBV_ILN_4333 | ||
912 | |a GBV_ILN_4334 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4393 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 13 |j 2021 |h e00209- |
author_variant |
k p f kp kpf w m p a wmp wmpa a b p a abp abpa a p l ap apl o d m o odm odmo |
---|---|
matchkey_str |
article:24056731:2021----::eorvlnefrpnsmeasicmluigateastcnqen |
hierarchy_sort_str |
2021 |
callnumber-subject-code |
RC |
publishDate |
2021 |
allfields |
10.1016/j.parepi.2021.e00209 doi (DE-627)DOAJ057023816 (DE-599)DOAJd58e8072a39c4a5cb9c283e77f4417ed DE-627 ger DE-627 rakwb eng RC109-216 Falmata Kyari, PhD verfasserin aut Seroprevalence of Trypanosoma evansi in camels using CATT/T. evansi technique in Borno and Yobe states, Nigeria 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Trypanosoma evansi is an important camel pathogen with dissimilar mammalian hosts and is the most widely distributed pathogenic animals' trypanosomes worldwide that affects domesticated animals. Four hundred and six blood samples were collected using homogeneous purposive sampling techniques from camels of all age groups (206 from Borno State and 200 from Yobe State, Nigeria). Each animal was examined and information on age and gender were recorded. The card agglutination test for T. evansi (CATT/T. evansi) was used to estimate the seroprevalence of T. evansi infection. The seroprevalence of T. evansi based on age and sex in Borno State, Nigeria was 38.83% (95% CI = 32.44%, 45.63%) in adult camels, whereas, the seroprevalence of T. evansi in young camels was significantly lower 2.91%, (95% CI = 1.34%, 6.20%), p < 0.05). The seroprevalence of T. evansi in male camels was estimated at 14.08% (95% CI = 9.99, 19.49) whereas, in female camels the seroprevalence was estimated at 27.67% (95% CI = 22.01%, 34.15%, p < 0.05). Furthermore, the seroprevalence of T. evansi in Yobe State, Nigeria in the adult camels was 27.50% (95% CI = 21.78%, 34.07%) whereas, the seroprevalence of T. evansi in young camels was 19.00%, (95% CI = 14.17%, 25.00%). The seroprevalence of T. evansi in male camels was 30.0% (95% CI = 24.07%, 36.68%), whereas, the seroprevalence of T. evansi in female camels was 16.5% (95% CI = 12.00%, 22.27%). Therefore, the present study aimed to provide information on the seroprevalence of T. evansi and the related risk factors in camels in Borno and Yobe States, Nigeria using CATT/T. evansi technique. Seroprevalence T. evansi Camels Borno Yobe Nigeria Infectious and parasitic diseases Albert Wulari Mbaya, PhD verfasserin aut Abdullahi Abubakar Biu, PhD verfasserin aut Lawan Adamu, PhD verfasserin aut Okoro Ogbonna Dennis, MVSc verfasserin aut In Parasite Epidemiology and Control Elsevier, 2018 13(2021), Seite e00209- (DE-627)861102487 (DE-600)2858649-9 24056731 nnns volume:13 year:2021 pages:e00209- https://doi.org/10.1016/j.parepi.2021.e00209 kostenfrei https://doaj.org/article/d58e8072a39c4a5cb9c283e77f4417ed kostenfrei http://www.sciencedirect.com/science/article/pii/S2405673121000106 kostenfrei https://doaj.org/toc/2405-6731 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2007 GBV_ILN_2008 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2026 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2050 GBV_ILN_2055 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2088 GBV_ILN_2106 GBV_ILN_2110 GBV_ILN_2112 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2232 GBV_ILN_2336 GBV_ILN_2470 GBV_ILN_2507 GBV_ILN_4012 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4249 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4393 GBV_ILN_4700 AR 13 2021 e00209- |
spelling |
10.1016/j.parepi.2021.e00209 doi (DE-627)DOAJ057023816 (DE-599)DOAJd58e8072a39c4a5cb9c283e77f4417ed DE-627 ger DE-627 rakwb eng RC109-216 Falmata Kyari, PhD verfasserin aut Seroprevalence of Trypanosoma evansi in camels using CATT/T. evansi technique in Borno and Yobe states, Nigeria 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Trypanosoma evansi is an important camel pathogen with dissimilar mammalian hosts and is the most widely distributed pathogenic animals' trypanosomes worldwide that affects domesticated animals. Four hundred and six blood samples were collected using homogeneous purposive sampling techniques from camels of all age groups (206 from Borno State and 200 from Yobe State, Nigeria). Each animal was examined and information on age and gender were recorded. The card agglutination test for T. evansi (CATT/T. evansi) was used to estimate the seroprevalence of T. evansi infection. The seroprevalence of T. evansi based on age and sex in Borno State, Nigeria was 38.83% (95% CI = 32.44%, 45.63%) in adult camels, whereas, the seroprevalence of T. evansi in young camels was significantly lower 2.91%, (95% CI = 1.34%, 6.20%), p < 0.05). The seroprevalence of T. evansi in male camels was estimated at 14.08% (95% CI = 9.99, 19.49) whereas, in female camels the seroprevalence was estimated at 27.67% (95% CI = 22.01%, 34.15%, p < 0.05). Furthermore, the seroprevalence of T. evansi in Yobe State, Nigeria in the adult camels was 27.50% (95% CI = 21.78%, 34.07%) whereas, the seroprevalence of T. evansi in young camels was 19.00%, (95% CI = 14.17%, 25.00%). The seroprevalence of T. evansi in male camels was 30.0% (95% CI = 24.07%, 36.68%), whereas, the seroprevalence of T. evansi in female camels was 16.5% (95% CI = 12.00%, 22.27%). Therefore, the present study aimed to provide information on the seroprevalence of T. evansi and the related risk factors in camels in Borno and Yobe States, Nigeria using CATT/T. evansi technique. Seroprevalence T. evansi Camels Borno Yobe Nigeria Infectious and parasitic diseases Albert Wulari Mbaya, PhD verfasserin aut Abdullahi Abubakar Biu, PhD verfasserin aut Lawan Adamu, PhD verfasserin aut Okoro Ogbonna Dennis, MVSc verfasserin aut In Parasite Epidemiology and Control Elsevier, 2018 13(2021), Seite e00209- (DE-627)861102487 (DE-600)2858649-9 24056731 nnns volume:13 year:2021 pages:e00209- https://doi.org/10.1016/j.parepi.2021.e00209 kostenfrei https://doaj.org/article/d58e8072a39c4a5cb9c283e77f4417ed kostenfrei http://www.sciencedirect.com/science/article/pii/S2405673121000106 kostenfrei https://doaj.org/toc/2405-6731 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2007 GBV_ILN_2008 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2026 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2050 GBV_ILN_2055 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2088 GBV_ILN_2106 GBV_ILN_2110 GBV_ILN_2112 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2232 GBV_ILN_2336 GBV_ILN_2470 GBV_ILN_2507 GBV_ILN_4012 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4249 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4393 GBV_ILN_4700 AR 13 2021 e00209- |
allfields_unstemmed |
10.1016/j.parepi.2021.e00209 doi (DE-627)DOAJ057023816 (DE-599)DOAJd58e8072a39c4a5cb9c283e77f4417ed DE-627 ger DE-627 rakwb eng RC109-216 Falmata Kyari, PhD verfasserin aut Seroprevalence of Trypanosoma evansi in camels using CATT/T. evansi technique in Borno and Yobe states, Nigeria 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Trypanosoma evansi is an important camel pathogen with dissimilar mammalian hosts and is the most widely distributed pathogenic animals' trypanosomes worldwide that affects domesticated animals. Four hundred and six blood samples were collected using homogeneous purposive sampling techniques from camels of all age groups (206 from Borno State and 200 from Yobe State, Nigeria). Each animal was examined and information on age and gender were recorded. The card agglutination test for T. evansi (CATT/T. evansi) was used to estimate the seroprevalence of T. evansi infection. The seroprevalence of T. evansi based on age and sex in Borno State, Nigeria was 38.83% (95% CI = 32.44%, 45.63%) in adult camels, whereas, the seroprevalence of T. evansi in young camels was significantly lower 2.91%, (95% CI = 1.34%, 6.20%), p < 0.05). The seroprevalence of T. evansi in male camels was estimated at 14.08% (95% CI = 9.99, 19.49) whereas, in female camels the seroprevalence was estimated at 27.67% (95% CI = 22.01%, 34.15%, p < 0.05). Furthermore, the seroprevalence of T. evansi in Yobe State, Nigeria in the adult camels was 27.50% (95% CI = 21.78%, 34.07%) whereas, the seroprevalence of T. evansi in young camels was 19.00%, (95% CI = 14.17%, 25.00%). The seroprevalence of T. evansi in male camels was 30.0% (95% CI = 24.07%, 36.68%), whereas, the seroprevalence of T. evansi in female camels was 16.5% (95% CI = 12.00%, 22.27%). Therefore, the present study aimed to provide information on the seroprevalence of T. evansi and the related risk factors in camels in Borno and Yobe States, Nigeria using CATT/T. evansi technique. Seroprevalence T. evansi Camels Borno Yobe Nigeria Infectious and parasitic diseases Albert Wulari Mbaya, PhD verfasserin aut Abdullahi Abubakar Biu, PhD verfasserin aut Lawan Adamu, PhD verfasserin aut Okoro Ogbonna Dennis, MVSc verfasserin aut In Parasite Epidemiology and Control Elsevier, 2018 13(2021), Seite e00209- (DE-627)861102487 (DE-600)2858649-9 24056731 nnns volume:13 year:2021 pages:e00209- https://doi.org/10.1016/j.parepi.2021.e00209 kostenfrei https://doaj.org/article/d58e8072a39c4a5cb9c283e77f4417ed kostenfrei http://www.sciencedirect.com/science/article/pii/S2405673121000106 kostenfrei https://doaj.org/toc/2405-6731 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2007 GBV_ILN_2008 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2026 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2050 GBV_ILN_2055 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2088 GBV_ILN_2106 GBV_ILN_2110 GBV_ILN_2112 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2232 GBV_ILN_2336 GBV_ILN_2470 GBV_ILN_2507 GBV_ILN_4012 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4249 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4393 GBV_ILN_4700 AR 13 2021 e00209- |
allfieldsGer |
10.1016/j.parepi.2021.e00209 doi (DE-627)DOAJ057023816 (DE-599)DOAJd58e8072a39c4a5cb9c283e77f4417ed DE-627 ger DE-627 rakwb eng RC109-216 Falmata Kyari, PhD verfasserin aut Seroprevalence of Trypanosoma evansi in camels using CATT/T. evansi technique in Borno and Yobe states, Nigeria 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Trypanosoma evansi is an important camel pathogen with dissimilar mammalian hosts and is the most widely distributed pathogenic animals' trypanosomes worldwide that affects domesticated animals. Four hundred and six blood samples were collected using homogeneous purposive sampling techniques from camels of all age groups (206 from Borno State and 200 from Yobe State, Nigeria). Each animal was examined and information on age and gender were recorded. The card agglutination test for T. evansi (CATT/T. evansi) was used to estimate the seroprevalence of T. evansi infection. The seroprevalence of T. evansi based on age and sex in Borno State, Nigeria was 38.83% (95% CI = 32.44%, 45.63%) in adult camels, whereas, the seroprevalence of T. evansi in young camels was significantly lower 2.91%, (95% CI = 1.34%, 6.20%), p < 0.05). The seroprevalence of T. evansi in male camels was estimated at 14.08% (95% CI = 9.99, 19.49) whereas, in female camels the seroprevalence was estimated at 27.67% (95% CI = 22.01%, 34.15%, p < 0.05). Furthermore, the seroprevalence of T. evansi in Yobe State, Nigeria in the adult camels was 27.50% (95% CI = 21.78%, 34.07%) whereas, the seroprevalence of T. evansi in young camels was 19.00%, (95% CI = 14.17%, 25.00%). The seroprevalence of T. evansi in male camels was 30.0% (95% CI = 24.07%, 36.68%), whereas, the seroprevalence of T. evansi in female camels was 16.5% (95% CI = 12.00%, 22.27%). Therefore, the present study aimed to provide information on the seroprevalence of T. evansi and the related risk factors in camels in Borno and Yobe States, Nigeria using CATT/T. evansi technique. Seroprevalence T. evansi Camels Borno Yobe Nigeria Infectious and parasitic diseases Albert Wulari Mbaya, PhD verfasserin aut Abdullahi Abubakar Biu, PhD verfasserin aut Lawan Adamu, PhD verfasserin aut Okoro Ogbonna Dennis, MVSc verfasserin aut In Parasite Epidemiology and Control Elsevier, 2018 13(2021), Seite e00209- (DE-627)861102487 (DE-600)2858649-9 24056731 nnns volume:13 year:2021 pages:e00209- https://doi.org/10.1016/j.parepi.2021.e00209 kostenfrei https://doaj.org/article/d58e8072a39c4a5cb9c283e77f4417ed kostenfrei http://www.sciencedirect.com/science/article/pii/S2405673121000106 kostenfrei https://doaj.org/toc/2405-6731 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2007 GBV_ILN_2008 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2026 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2050 GBV_ILN_2055 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2088 GBV_ILN_2106 GBV_ILN_2110 GBV_ILN_2112 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2232 GBV_ILN_2336 GBV_ILN_2470 GBV_ILN_2507 GBV_ILN_4012 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4249 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4393 GBV_ILN_4700 AR 13 2021 e00209- |
allfieldsSound |
10.1016/j.parepi.2021.e00209 doi (DE-627)DOAJ057023816 (DE-599)DOAJd58e8072a39c4a5cb9c283e77f4417ed DE-627 ger DE-627 rakwb eng RC109-216 Falmata Kyari, PhD verfasserin aut Seroprevalence of Trypanosoma evansi in camels using CATT/T. evansi technique in Borno and Yobe states, Nigeria 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Trypanosoma evansi is an important camel pathogen with dissimilar mammalian hosts and is the most widely distributed pathogenic animals' trypanosomes worldwide that affects domesticated animals. Four hundred and six blood samples were collected using homogeneous purposive sampling techniques from camels of all age groups (206 from Borno State and 200 from Yobe State, Nigeria). Each animal was examined and information on age and gender were recorded. The card agglutination test for T. evansi (CATT/T. evansi) was used to estimate the seroprevalence of T. evansi infection. The seroprevalence of T. evansi based on age and sex in Borno State, Nigeria was 38.83% (95% CI = 32.44%, 45.63%) in adult camels, whereas, the seroprevalence of T. evansi in young camels was significantly lower 2.91%, (95% CI = 1.34%, 6.20%), p < 0.05). The seroprevalence of T. evansi in male camels was estimated at 14.08% (95% CI = 9.99, 19.49) whereas, in female camels the seroprevalence was estimated at 27.67% (95% CI = 22.01%, 34.15%, p < 0.05). Furthermore, the seroprevalence of T. evansi in Yobe State, Nigeria in the adult camels was 27.50% (95% CI = 21.78%, 34.07%) whereas, the seroprevalence of T. evansi in young camels was 19.00%, (95% CI = 14.17%, 25.00%). The seroprevalence of T. evansi in male camels was 30.0% (95% CI = 24.07%, 36.68%), whereas, the seroprevalence of T. evansi in female camels was 16.5% (95% CI = 12.00%, 22.27%). Therefore, the present study aimed to provide information on the seroprevalence of T. evansi and the related risk factors in camels in Borno and Yobe States, Nigeria using CATT/T. evansi technique. Seroprevalence T. evansi Camels Borno Yobe Nigeria Infectious and parasitic diseases Albert Wulari Mbaya, PhD verfasserin aut Abdullahi Abubakar Biu, PhD verfasserin aut Lawan Adamu, PhD verfasserin aut Okoro Ogbonna Dennis, MVSc verfasserin aut In Parasite Epidemiology and Control Elsevier, 2018 13(2021), Seite e00209- (DE-627)861102487 (DE-600)2858649-9 24056731 nnns volume:13 year:2021 pages:e00209- https://doi.org/10.1016/j.parepi.2021.e00209 kostenfrei https://doaj.org/article/d58e8072a39c4a5cb9c283e77f4417ed kostenfrei http://www.sciencedirect.com/science/article/pii/S2405673121000106 kostenfrei https://doaj.org/toc/2405-6731 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2007 GBV_ILN_2008 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2026 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2050 GBV_ILN_2055 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2088 GBV_ILN_2106 GBV_ILN_2110 GBV_ILN_2112 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2232 GBV_ILN_2336 GBV_ILN_2470 GBV_ILN_2507 GBV_ILN_4012 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4249 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4393 GBV_ILN_4700 AR 13 2021 e00209- |
language |
English |
source |
In Parasite Epidemiology and Control 13(2021), Seite e00209- volume:13 year:2021 pages:e00209- |
sourceStr |
In Parasite Epidemiology and Control 13(2021), Seite e00209- volume:13 year:2021 pages:e00209- |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Seroprevalence T. evansi Camels Borno Yobe Nigeria Infectious and parasitic diseases |
isfreeaccess_bool |
true |
container_title |
Parasite Epidemiology and Control |
authorswithroles_txt_mv |
Falmata Kyari, PhD @@aut@@ Albert Wulari Mbaya, PhD @@aut@@ Abdullahi Abubakar Biu, PhD @@aut@@ Lawan Adamu, PhD @@aut@@ Okoro Ogbonna Dennis, MVSc @@aut@@ |
publishDateDaySort_date |
2021-01-01T00:00:00Z |
hierarchy_top_id |
861102487 |
id |
DOAJ057023816 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ057023816</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230502133644.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.parepi.2021.e00209</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ057023816</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJd58e8072a39c4a5cb9c283e77f4417ed</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC109-216</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Falmata Kyari, PhD</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Seroprevalence of Trypanosoma evansi in camels using CATT/T. evansi technique in Borno and Yobe states, Nigeria</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Trypanosoma evansi is an important camel pathogen with dissimilar mammalian hosts and is the most widely distributed pathogenic animals' trypanosomes worldwide that affects domesticated animals. Four hundred and six blood samples were collected using homogeneous purposive sampling techniques from camels of all age groups (206 from Borno State and 200 from Yobe State, Nigeria). Each animal was examined and information on age and gender were recorded. The card agglutination test for T. evansi (CATT/T. evansi) was used to estimate the seroprevalence of T. evansi infection. The seroprevalence of T. evansi based on age and sex in Borno State, Nigeria was 38.83% (95% CI = 32.44%, 45.63%) in adult camels, whereas, the seroprevalence of T. evansi in young camels was significantly lower 2.91%, (95% CI = 1.34%, 6.20%), p < 0.05). The seroprevalence of T. evansi in male camels was estimated at 14.08% (95% CI = 9.99, 19.49) whereas, in female camels the seroprevalence was estimated at 27.67% (95% CI = 22.01%, 34.15%, p < 0.05). Furthermore, the seroprevalence of T. evansi in Yobe State, Nigeria in the adult camels was 27.50% (95% CI = 21.78%, 34.07%) whereas, the seroprevalence of T. evansi in young camels was 19.00%, (95% CI = 14.17%, 25.00%). The seroprevalence of T. evansi in male camels was 30.0% (95% CI = 24.07%, 36.68%), whereas, the seroprevalence of T. evansi in female camels was 16.5% (95% CI = 12.00%, 22.27%). Therefore, the present study aimed to provide information on the seroprevalence of T. evansi and the related risk factors in camels in Borno and Yobe States, Nigeria using CATT/T. evansi technique.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Seroprevalence</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">T. evansi</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Camels</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Borno</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Yobe</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nigeria</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Infectious and parasitic diseases</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Albert Wulari Mbaya, PhD</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Abdullahi Abubakar Biu, PhD</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Lawan Adamu, PhD</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Okoro Ogbonna Dennis, MVSc</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Parasite Epidemiology and Control</subfield><subfield code="d">Elsevier, 2018</subfield><subfield code="g">13(2021), Seite e00209-</subfield><subfield code="w">(DE-627)861102487</subfield><subfield code="w">(DE-600)2858649-9</subfield><subfield code="x">24056731</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:13</subfield><subfield code="g">year:2021</subfield><subfield code="g">pages:e00209-</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.parepi.2021.e00209</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/d58e8072a39c4a5cb9c283e77f4417ed</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/article/pii/S2405673121000106</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2405-6731</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_224</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2001</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2006</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2007</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2008</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2010</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2015</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2020</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2021</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2025</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2026</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2027</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2034</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2038</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2044</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2048</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2050</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2056</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2059</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2061</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2064</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2088</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2106</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2122</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2129</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2143</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2152</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2153</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2232</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2336</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2470</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2507</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4035</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4242</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4251</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4326</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4333</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4334</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4393</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">13</subfield><subfield code="j">2021</subfield><subfield code="h">e00209-</subfield></datafield></record></collection>
|
callnumber-first |
R - Medicine |
author |
Falmata Kyari, PhD |
spellingShingle |
Falmata Kyari, PhD misc RC109-216 misc Seroprevalence misc T. evansi misc Camels misc Borno misc Yobe misc Nigeria misc Infectious and parasitic diseases Seroprevalence of Trypanosoma evansi in camels using CATT/T. evansi technique in Borno and Yobe states, Nigeria |
authorStr |
Falmata Kyari, PhD |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)861102487 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
RC109-216 |
illustrated |
Not Illustrated |
issn |
24056731 |
topic_title |
RC109-216 Seroprevalence of Trypanosoma evansi in camels using CATT/T. evansi technique in Borno and Yobe states, Nigeria Seroprevalence T. evansi Camels Borno Yobe Nigeria |
topic |
misc RC109-216 misc Seroprevalence misc T. evansi misc Camels misc Borno misc Yobe misc Nigeria misc Infectious and parasitic diseases |
topic_unstemmed |
misc RC109-216 misc Seroprevalence misc T. evansi misc Camels misc Borno misc Yobe misc Nigeria misc Infectious and parasitic diseases |
topic_browse |
misc RC109-216 misc Seroprevalence misc T. evansi misc Camels misc Borno misc Yobe misc Nigeria misc Infectious and parasitic diseases |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Parasite Epidemiology and Control |
hierarchy_parent_id |
861102487 |
hierarchy_top_title |
Parasite Epidemiology and Control |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)861102487 (DE-600)2858649-9 |
title |
Seroprevalence of Trypanosoma evansi in camels using CATT/T. evansi technique in Borno and Yobe states, Nigeria |
ctrlnum |
(DE-627)DOAJ057023816 (DE-599)DOAJd58e8072a39c4a5cb9c283e77f4417ed |
title_full |
Seroprevalence of Trypanosoma evansi in camels using CATT/T. evansi technique in Borno and Yobe states, Nigeria |
author_sort |
Falmata Kyari, PhD |
journal |
Parasite Epidemiology and Control |
journalStr |
Parasite Epidemiology and Control |
callnumber-first-code |
R |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2021 |
contenttype_str_mv |
txt |
author_browse |
Falmata Kyari, PhD Albert Wulari Mbaya, PhD Abdullahi Abubakar Biu, PhD Lawan Adamu, PhD Okoro Ogbonna Dennis, MVSc |
container_volume |
13 |
class |
RC109-216 |
format_se |
Elektronische Aufsätze |
author-letter |
Falmata Kyari, PhD |
doi_str_mv |
10.1016/j.parepi.2021.e00209 |
author2-role |
verfasserin |
title_sort |
seroprevalence of trypanosoma evansi in camels using catt/t. evansi technique in borno and yobe states, nigeria |
callnumber |
RC109-216 |
title_auth |
Seroprevalence of Trypanosoma evansi in camels using CATT/T. evansi technique in Borno and Yobe states, Nigeria |
abstract |
Trypanosoma evansi is an important camel pathogen with dissimilar mammalian hosts and is the most widely distributed pathogenic animals' trypanosomes worldwide that affects domesticated animals. Four hundred and six blood samples were collected using homogeneous purposive sampling techniques from camels of all age groups (206 from Borno State and 200 from Yobe State, Nigeria). Each animal was examined and information on age and gender were recorded. The card agglutination test for T. evansi (CATT/T. evansi) was used to estimate the seroprevalence of T. evansi infection. The seroprevalence of T. evansi based on age and sex in Borno State, Nigeria was 38.83% (95% CI = 32.44%, 45.63%) in adult camels, whereas, the seroprevalence of T. evansi in young camels was significantly lower 2.91%, (95% CI = 1.34%, 6.20%), p < 0.05). The seroprevalence of T. evansi in male camels was estimated at 14.08% (95% CI = 9.99, 19.49) whereas, in female camels the seroprevalence was estimated at 27.67% (95% CI = 22.01%, 34.15%, p < 0.05). Furthermore, the seroprevalence of T. evansi in Yobe State, Nigeria in the adult camels was 27.50% (95% CI = 21.78%, 34.07%) whereas, the seroprevalence of T. evansi in young camels was 19.00%, (95% CI = 14.17%, 25.00%). The seroprevalence of T. evansi in male camels was 30.0% (95% CI = 24.07%, 36.68%), whereas, the seroprevalence of T. evansi in female camels was 16.5% (95% CI = 12.00%, 22.27%). Therefore, the present study aimed to provide information on the seroprevalence of T. evansi and the related risk factors in camels in Borno and Yobe States, Nigeria using CATT/T. evansi technique. |
abstractGer |
Trypanosoma evansi is an important camel pathogen with dissimilar mammalian hosts and is the most widely distributed pathogenic animals' trypanosomes worldwide that affects domesticated animals. Four hundred and six blood samples were collected using homogeneous purposive sampling techniques from camels of all age groups (206 from Borno State and 200 from Yobe State, Nigeria). Each animal was examined and information on age and gender were recorded. The card agglutination test for T. evansi (CATT/T. evansi) was used to estimate the seroprevalence of T. evansi infection. The seroprevalence of T. evansi based on age and sex in Borno State, Nigeria was 38.83% (95% CI = 32.44%, 45.63%) in adult camels, whereas, the seroprevalence of T. evansi in young camels was significantly lower 2.91%, (95% CI = 1.34%, 6.20%), p < 0.05). The seroprevalence of T. evansi in male camels was estimated at 14.08% (95% CI = 9.99, 19.49) whereas, in female camels the seroprevalence was estimated at 27.67% (95% CI = 22.01%, 34.15%, p < 0.05). Furthermore, the seroprevalence of T. evansi in Yobe State, Nigeria in the adult camels was 27.50% (95% CI = 21.78%, 34.07%) whereas, the seroprevalence of T. evansi in young camels was 19.00%, (95% CI = 14.17%, 25.00%). The seroprevalence of T. evansi in male camels was 30.0% (95% CI = 24.07%, 36.68%), whereas, the seroprevalence of T. evansi in female camels was 16.5% (95% CI = 12.00%, 22.27%). Therefore, the present study aimed to provide information on the seroprevalence of T. evansi and the related risk factors in camels in Borno and Yobe States, Nigeria using CATT/T. evansi technique. |
abstract_unstemmed |
Trypanosoma evansi is an important camel pathogen with dissimilar mammalian hosts and is the most widely distributed pathogenic animals' trypanosomes worldwide that affects domesticated animals. Four hundred and six blood samples were collected using homogeneous purposive sampling techniques from camels of all age groups (206 from Borno State and 200 from Yobe State, Nigeria). Each animal was examined and information on age and gender were recorded. The card agglutination test for T. evansi (CATT/T. evansi) was used to estimate the seroprevalence of T. evansi infection. The seroprevalence of T. evansi based on age and sex in Borno State, Nigeria was 38.83% (95% CI = 32.44%, 45.63%) in adult camels, whereas, the seroprevalence of T. evansi in young camels was significantly lower 2.91%, (95% CI = 1.34%, 6.20%), p < 0.05). The seroprevalence of T. evansi in male camels was estimated at 14.08% (95% CI = 9.99, 19.49) whereas, in female camels the seroprevalence was estimated at 27.67% (95% CI = 22.01%, 34.15%, p < 0.05). Furthermore, the seroprevalence of T. evansi in Yobe State, Nigeria in the adult camels was 27.50% (95% CI = 21.78%, 34.07%) whereas, the seroprevalence of T. evansi in young camels was 19.00%, (95% CI = 14.17%, 25.00%). The seroprevalence of T. evansi in male camels was 30.0% (95% CI = 24.07%, 36.68%), whereas, the seroprevalence of T. evansi in female camels was 16.5% (95% CI = 12.00%, 22.27%). Therefore, the present study aimed to provide information on the seroprevalence of T. evansi and the related risk factors in camels in Borno and Yobe States, Nigeria using CATT/T. evansi technique. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2007 GBV_ILN_2008 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2026 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2050 GBV_ILN_2055 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2088 GBV_ILN_2106 GBV_ILN_2110 GBV_ILN_2112 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2232 GBV_ILN_2336 GBV_ILN_2470 GBV_ILN_2507 GBV_ILN_4012 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4249 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4393 GBV_ILN_4700 |
title_short |
Seroprevalence of Trypanosoma evansi in camels using CATT/T. evansi technique in Borno and Yobe states, Nigeria |
url |
https://doi.org/10.1016/j.parepi.2021.e00209 https://doaj.org/article/d58e8072a39c4a5cb9c283e77f4417ed http://www.sciencedirect.com/science/article/pii/S2405673121000106 https://doaj.org/toc/2405-6731 |
remote_bool |
true |
author2 |
Albert Wulari Mbaya, PhD Abdullahi Abubakar Biu, PhD Lawan Adamu, PhD Okoro Ogbonna Dennis, MVSc |
author2Str |
Albert Wulari Mbaya, PhD Abdullahi Abubakar Biu, PhD Lawan Adamu, PhD Okoro Ogbonna Dennis, MVSc |
ppnlink |
861102487 |
callnumber-subject |
RC - Internal Medicine |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.1016/j.parepi.2021.e00209 |
callnumber-a |
RC109-216 |
up_date |
2024-07-03T23:59:59.419Z |
_version_ |
1803604406484074496 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ057023816</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230502133644.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.parepi.2021.e00209</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ057023816</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJd58e8072a39c4a5cb9c283e77f4417ed</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC109-216</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Falmata Kyari, PhD</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Seroprevalence of Trypanosoma evansi in camels using CATT/T. evansi technique in Borno and Yobe states, Nigeria</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Trypanosoma evansi is an important camel pathogen with dissimilar mammalian hosts and is the most widely distributed pathogenic animals' trypanosomes worldwide that affects domesticated animals. Four hundred and six blood samples were collected using homogeneous purposive sampling techniques from camels of all age groups (206 from Borno State and 200 from Yobe State, Nigeria). Each animal was examined and information on age and gender were recorded. The card agglutination test for T. evansi (CATT/T. evansi) was used to estimate the seroprevalence of T. evansi infection. The seroprevalence of T. evansi based on age and sex in Borno State, Nigeria was 38.83% (95% CI = 32.44%, 45.63%) in adult camels, whereas, the seroprevalence of T. evansi in young camels was significantly lower 2.91%, (95% CI = 1.34%, 6.20%), p < 0.05). The seroprevalence of T. evansi in male camels was estimated at 14.08% (95% CI = 9.99, 19.49) whereas, in female camels the seroprevalence was estimated at 27.67% (95% CI = 22.01%, 34.15%, p < 0.05). Furthermore, the seroprevalence of T. evansi in Yobe State, Nigeria in the adult camels was 27.50% (95% CI = 21.78%, 34.07%) whereas, the seroprevalence of T. evansi in young camels was 19.00%, (95% CI = 14.17%, 25.00%). The seroprevalence of T. evansi in male camels was 30.0% (95% CI = 24.07%, 36.68%), whereas, the seroprevalence of T. evansi in female camels was 16.5% (95% CI = 12.00%, 22.27%). Therefore, the present study aimed to provide information on the seroprevalence of T. evansi and the related risk factors in camels in Borno and Yobe States, Nigeria using CATT/T. evansi technique.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Seroprevalence</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">T. evansi</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Camels</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Borno</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Yobe</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nigeria</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Infectious and parasitic diseases</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Albert Wulari Mbaya, PhD</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Abdullahi Abubakar Biu, PhD</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Lawan Adamu, PhD</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Okoro Ogbonna Dennis, MVSc</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Parasite Epidemiology and Control</subfield><subfield code="d">Elsevier, 2018</subfield><subfield code="g">13(2021), Seite e00209-</subfield><subfield code="w">(DE-627)861102487</subfield><subfield code="w">(DE-600)2858649-9</subfield><subfield code="x">24056731</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:13</subfield><subfield code="g">year:2021</subfield><subfield code="g">pages:e00209-</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.parepi.2021.e00209</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/d58e8072a39c4a5cb9c283e77f4417ed</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/article/pii/S2405673121000106</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2405-6731</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_224</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2001</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2006</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2007</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2008</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2010</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2015</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2020</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2021</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2025</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2026</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2027</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2034</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2038</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2044</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2048</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2050</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2056</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2059</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2061</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2064</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2088</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2106</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2122</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2129</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2143</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2152</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2153</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2232</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2336</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2470</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2507</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4035</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4242</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4251</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4326</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4333</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4334</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4393</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">13</subfield><subfield code="j">2021</subfield><subfield code="h">e00209-</subfield></datafield></record></collection>
|
score |
7.4019556 |